Rockefeller Capital Management L.P. Coherus Bio Sciences, Inc. Transaction History

Rockefeller Capital Management L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$7.17 - $13.87 $760 - $1,470	-106 Reduced 19.1%	449 $4,000
Q2 2022 Aug 12, 2022	BUY	$5.86 - $13.23 $1,353 - $3,056	231 Added 71.3%	555 $4,000
Q1 2022 May 13, 2022	SELL	$10.92 - $16.41 $120 - $180	-11 Reduced 3.28%	324 $4,000
Q4 2021 Feb 14, 2022	SELL	$15.81 - $18.99 $1,675 - $2,012	-106 Reduced 24.04%	335 $5,000
Q1 2021 May 11, 2021	BUY	$14.42 - $21.39 $6,359 - $9,432	441 New	441 $6,000
Q1 2020 May 12, 2020	SELL	$11.67 - $22.53 $46 - $90	-4 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$16.33 - $21.37 $65 - $85	4 New	4 $0

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $115M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.